ConductScience.org, home

Paper20107007

Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.

Mielcarek N and 3 others. Clin Vaccine Immunol, 2010. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Papers, record 20107007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20107007

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.
PubMed
Journal
Clin Vaccine Immunol
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
0.91
iCite
Revised in PubMed
2024-03-22
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mielcarek NNathalie
2Debrie ASAnne-Sophie
3Mahieux SSeverine
4Locht CCamille

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pertussis VaccineMajor topic
Administration, Intranasal
Animals
Antibodies, Bacterial
Bordetella pertussis
Enzyme-Linked Immunosorbent Assay
Female
Mice
Mice, Inbred BALB C
Vaccines, Attenuated
Whooping Cough

Source PubMed

Download CSV of topics

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01188512First Adult Safety Trial on Nasal Live Attenuated B. Pertussis VaccineBackgroundClinicalTrials.gov
NCT02453048Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis VaccineBackgroundClinicalTrials.gov
NCT03942406Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy AdultsBackgroundClinicalTrials.gov

Download CSV of trials

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115876930Potential strategies to reduce the burden of pertussis.Pediatr Infect Dis J2005https://conductscience.org/library/papers/15876930PubMed
22407655Construction and characterization in vivo of Bordetella pertussis aroA mutants.Infect Immun1990https://conductscience.org/library/papers/2407655PubMed
319751581Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.Emerg Infect Dis2009https://conductscience.org/library/papers/19751581PubMed
42341166Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin.Infect Immun1990https://conductscience.org/library/papers/2341166PubMed
518505398Factors contributing to pertussis resurgence.Future Microbiol2008https://conductscience.org/library/papers/18505398PubMed
612192169
Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids.
Pediatr Infect Dis J2002https://conductscience.org/library/papers/12192169PubMed
72956754Prevention of atrophic rhinitis in piglets by means of intranasal administration of a live non-AR-pathogenic Bordetella bronchiseptica vaccine.Vet Q1987https://conductscience.org/library/papers/2956754PubMed
811447159Immunoglobulin A-mediated protection against Bordetella pertussis infection.Infect Immun2001https://conductscience.org/library/papers/11447159PubMed
912538714Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses.J Immunol2003https://conductscience.org/library/papers/12538714PubMed
1011964852Pertussis: an old disease that is still with us.Curr Opin Infect Dis2001https://conductscience.org/library/papers/11964852PubMed
1110392618Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines.Vaccine1999https://conductscience.org/library/papers/10392618PubMed
126315733Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase.J Biol Chem1983https://conductscience.org/library/papers/6315733PubMed
1312728086Immunogenicity of a three-component acellular pertussis vaccine administered at birth.Pediatrics2003https://conductscience.org/library/papers/12728086PubMed
1417878939Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains.PLoS One2007https://conductscience.org/library/papers/17878939PubMed
1518560590Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination.PLoS One2008https://conductscience.org/library/papers/18560590PubMed
16525927Intranasal immunization of dogs against Bordetella bronchiseptica-induced tracheobronchitis (kennel cough) with modified live-Bordetella bronchiseptica vaccine.Am J Vet Res1979https://conductscience.org/library/papers/525927PubMed
1715788498Clinical practice. Pertussis--not just for kids.N Engl J Med2005https://conductscience.org/library/papers/15788498PubMed
188112848Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis.Infect Immun1994https://conductscience.org/library/papers/8112848PubMed
1914449563Experimental Whooping cough.N Engl J Med1962https://conductscience.org/library/papers/14449563PubMed
209009311Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.Infect Immun1997https://conductscience.org/library/papers/9009311PubMed

See all 31 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
40612502Protection of infant mice against pertussis, tuberculosis and influenza by co-administration of nasal pertussis vaccine candidate BPZE1 and BCG.iScience2025https://conductscience.org/library/papers/40612502PubMed
34276113Antibodies induced by oral immunization of mice with a recombinant protein produced in tobacco plants harboring Bordetella pertussis epitopes.Plant Cell Tissue Organ Cult2021https://conductscience.org/library/papers/34276113PubMed
34211481Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives.Front Immunol2021https://conductscience.org/library/papers/34211481PubMed
33318136Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.Infect Immun2021https://conductscience.org/library/papers/33318136PubMed
31921136Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections.Front Immunol2019https://conductscience.org/library/papers/31921136PubMed
30115992IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine.Mucosal Immunol2018https://conductscience.org/library/papers/30115992PubMed
29531137The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs.Infect Immun2018https://conductscience.org/library/papers/29531137PubMed
29125532A New Whooping Cough Vaccine That May Prevent Colonization and Transmission.Vaccines (Basel)2017https://conductscience.org/library/papers/29125532PubMed
26542059Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.Paediatr Drugs2015https://conductscience.org/library/papers/26542059PubMed
24421886
A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.
PLoS One2014https://conductscience.org/library/papers/24421886PubMed
24261996Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism.Am J Respir Crit Care Med2014https://conductscience.org/library/papers/24261996PubMed
23555631Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e.PLoS One2013https://conductscience.org/library/papers/23555631PubMed
21147936A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.Clin Vaccine Immunol2011https://conductscience.org/library/papers/21147936PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20107007

GET https://conductscience.org/api/papers/v1/20107007/references?page=2